DNA Methylation of NFATC2IP was recently identified as being causally related to body mass index. The present study aimed to examine the roles of the genetic variation, methylation and gene expression at this locus in adiposity changes in a 2-year weight-loss trial. Participants (n = 692) were genotyped and randomly assigned to 1 of the 4 reduced-calorie diets, DNA methylation was derived from stored blood samples at baseline (n = 48), and adipose tissue gene expression was measured in 96 volunteers. We found significant interactions of fat intake with the genetic (rs11150675) and transcriptional (ILMN_1725441) variations at the NFATC2IP locus on 2-year weight change (P interaction < .01). Similarly, cis-DNA methylation at cg26663590 of the NFATC2IP locus showed an opposite impact on weight-loss in response to high-fat vs low-fat diet (effect size, 4.62 vs −1.24 kg). Additionally, baseline methylation at cg26663590 causally mediated 52.8% of the effect of rs11150675 on 2-year weight-loss in the high-fat diet group (P = .01), whereas no such mediation was observed in the low-fat diet group. Our findings suggest potentially causal effects of genetic, epigenetic and transcriptional variations at the NFATC2IP locus on adiposity changes in response to dietary fat intake.
DNA Methylation of NFATC2IP was recently identified as being causally related to body mass index. The present study aimed to examine the roles of the genetic variation, methylation and gene expression at this locus in adiposity changes in a 2-year weight-loss trial. Participants (n = 692) were genotyped and randomly assigned to 1 of the 4 reduced-calorie diets, DNA methylation was derived from stored blood samples at baseline (n = 48), and adipose tissue gene expression was measured in 96 volunteers. We found significant interactions of fat intake with the genetic (rs11150675) and transcriptional (ILMN_1725441) variations at the NFATC2IP locus on 2-year weight change (P interaction < .01). Similarly, cis-DNA methylation at cg26663590 of the NFATC2IP locus showed an opposite impact on weight-loss in response to high-fat vs low-fat diet (effect size, 4.62 vs −1.24 kg). Additionally, baseline methylation at cg26663590 causally mediated 52.8% of the effect of rs11150675 on 2-year weight-loss in the high-fat diet group (P = .01), whereas no such mediation was observed in the low-fat diet group. Our findings suggest potentially causal effects of genetic, epigenetic and transcriptional variations at the NFATC2IP locus on adiposity changes in response to dietary fat intake. Diet intervention is among the mainstream approaches to promote weight loss and mitigate cardiometabolic complications. 2 Given that only a limited proportion of individual variability in weight loss interventions can be explained by genetic variations, it seems that other mechanisms are also involved. 3, 4 In an epigenome-wide association study, Wahl et al. 5 identified only a single potential causal pathway linking NFATC2IP genetic polymorphism (rs11150675), cis-DNA methylation (DNAm) at cg26663590 CpG sites and body mass index (BMI). However, their study did not analyse whether the NFATC2IP pathway affected adiposity changes in response to dietary intervention.
We performed longitudinal analyses to examine the impact of the NFATC2IP rs11150675 genotype on changes in adiposity (body weight, fat distribution and body composition) in the 2-year Preventing Overweight Using Novel Dietary Strategies (POUNDS LOST) trial.
We tested in particular the potential interactions between dietary interventions and NFATC2IP genotype, cis-DNAm and gene expression on 2-year weight change. Prospective analyses were also performed to access the methylation-mediated effects of NFATC2IP genotype on weight change. In addition, we evaluated diet-induced changes in NFATC2IP gene expression at 6 months and further tested its relation with 2-year weight change.
| MATERIALS AND METHODS

| Study population
The POUNDS Lost Trail (ClinicalTrials.gov NCT00072995) is a randomized intervention trial in which 811 overweight and obese (BMI, 25-40 kg/m 2 ) individuals were assigned to 1 of 4 energy-reduced diets that varyied in macronutrients, to compare their effects on changes in adiposity over 2 years. 6 Among these, 2 diets were low-fat (20%) and the other 2 were high-fat (40%); 2 diets were averageprotein (15%) and the other 2 were high-protein (25%), which constituted a 2-by-2 factorial design. The 2 high-fat diets were also low-carbohydrate diets, and the 2 low-fat diets were highcarbohydrate diets. More details of this trial have been described in detail elsewhere. 6 The study was approved by 2 human subjects committees and by a data safety monitoring board appointed by the National Heart, Lung and Blood Institute. 6 Written informed consent was given by each participant.
| Measurements
Body weight was measured in the morning before breakfast at baseline and at 6, 12, 18 months and 2 years. Body composition was analysed in a random sample of~50% of enrolled participants by a dualenergy X-ray absorptiometry (DEXA) scan, using a Hologic QDR 4500A after an overnight fast. 7 Total fat mass (FM), total fat-free mass (FFM) and trunk fat percentage were obtained at baseline and at 6 months and 2 years of the intervention. Among individuals who underwent DEXA scans,~50% were randomly assigned to receive computed tomography (CT) scans for total (TAT), visceral (VAT), deep (DSAT) and superficial (SSAT) subcutaneous abdominal fat masses. 7 
| Genotyping, methylation and gene expression
The genotype success rate was 99%; replicate quality control samples (10%) were included and were genotyped, with >99% concordance.
Single-nucleotide polymorphism (SNP) rs11150675 near the NFAT-C2IP gene was genotyped in 692 participants using the OpenArray SNP Genotyping System (BioTrove, Woburn, Massachusetts). A genome-wide DNAm scan was performed in DNA derived from peripheral blood leukocytes with stored baseline blood samples in 48 white participants (high-and low-responders to 4 weight-loss diets at 2 years), using the Infinium Human Methylation 450 bead chip (Illumina, San Diego, California). 98% of the probes passed quality control. Data were normalized using Tost normalization and ComBat normalization function, 8 and the relative proportions of 6 pure cell types were estimated using the R package Minfi (https:// bioconductor.org/packages/release/bioc/html/minfi.html). .01 and were log2-transformed, and 1 probe (ILMN_1725441) at the NFATC2IP gene was extracted. Genome region information at the NFATC2IP locus is shown in Figure S3 , File S1.
| Statistical analysis
The primary outcome in the present study was weight change, with changes in body composition and abdominal fat distribution as secondary outcomes. Generalized linear mixed models were used to test potential interactions between the genetic effect (rs11150675), the epigenetic effect (cg26663590) and the transcriptional effect All P values were nominal and 2-sided, and a P value < .05 was considered statistically significant. Statistical analyses were performed with R version 3.3.2 (2016-10-31).
| RESULTS
Study characteristics and a flowchart are presented in Table S1 and Figure S1 , respectively File S1. Of 692 participants who were genotyped, the average age was 51.4 years, 61.1% were females and 84.2%
were White. No significant difference was found in age, dietary intake, BMI, weight, body composition, fat distribution, DNAm and gene expression between the NFATC2IP genotypes (P > .05). Over a 2-year period of intervention, we found that the genotype determining DNAm at the NFATC2IP locus (cis-meQTL rs11150675) was significantly associated with greater reduction in fat mass rather than lean mass (Appendix S2, Table S2 , Figure S4A and S4B, File S1). Overall compliance with the dietary intervention was accessed by nutrient intake and biomarkers of adherence (Appendix S1, File S1), and we did not observe a significant difference (Table S3 , File S1).
Intriguingly, we found a significant interaction between the rs11150675 genotype and low-/high-fat diet concerning the 2-year weight change (P interaction = 0.005) ( Figure 1A) . In response to the FIGURE 1 Genetic A, epigenetic B, and transcriptional C, variations at the NFATC2IP locus with weight loss in response to diet interventions varying in fat. Generalized linear mixed models (GLMM) were used to test potential interactions between genetic effect (SNP rs11150675), epigenetic effect (DNA methylation at cg26663590 CpG site) and transcriptional effect (gene expression at ILMN_1725441) with diet interventions varying in fat intake on the trajectory of weight change from baseline to 2 years. A genotype-by-diet term (rs11150675 non A/A allele carriers × high-/low-fat diet group) was included in the GLMM, as well as methylation-by-diet term (lower-/higher-methylation at cg26663590 × high−/low-fat diet group) and gene expression-by-diet term (lower-/higher-expression at ILMN_1725441 × high−/low-fat diet group). In the GLMM, covariates included age, gender, race, smoking status and BMI at baseline as fixed-effects, and intervention time within individuals as random effect. GLMM was also used to calculate regression coefficients (effect size) of genetic (reference group: non-A allele carriers), epigenetic (reference group: participants with a higher NFATC2IP DNA methylation level at baseline) and transcriptional (reference group: participants with a lower NFATC2IP gene expression level at baseline) variant on weight change in high-fat and low-fat diet groups, separately. Medians of methylation and gene expression level were used as cutoff points to divide participants into 2 groups (lower vs higher)
high-fat diet, carrying the A allele was marginally associated with a greater decrease in weight. Conversely, significantly less decrease in weight was observed among the A allele carriers, in response to the low-fat diet. We also found that dietary fat considerably modified the association between the adipose tissue NFATC2IP gene expression (ILMN_1725441) at baseline and 2-year weight loss (P interaction < 0.001) ( Figure 1C) . Similarly, a lower NFATC2IP methylation level at cg26663590 showed opposite associations with weight loss in response to high-fat vs low-fat diets (effect size, −4.62 vs 1.24) ( Figure 1B ).
We performed mediation analyses of the relationship between the NFATC2IP genotype (rs11150675 A allele), DNAm (cg26663 590) and weight change, as well as the estimated mediation effect (%) through DNAm, stratified by diet intervention groups. In the high-fat group, the methylation level at cg26663590 at baseline mediated an estimated 52.8% effect of the NFATC2IP rs11150675 genotype on weight change over 2 years (P < .01) ( Figure 2B ), whereas no such mediation effects were observed in the low-fat group (P = .80) ( Figure 2C ). Carrying the rs11150675 A allele was associated with a lower methylation level at cg26663590 (P < .05) (Figure 2A ). In addition, we found that a high-fat diet led to downregulated NFATC2IP gene expression (months 0 to 6), which was further associated with less weight loss (months 6 to 24) (Appendix S3 and Figure S2 , File S1).
| DISCUSSION
In this 2-year randomized controlled trial (RCT), dietary fat intake significantly modified the effect of the genetic (rs11150675), epigenetic (cg26663590) and transcriptional (ILMN_1725441) variations at the NFATC2IP locus on the long-term trajectory of weight change. Further, we found that NFATC2IP methylation mediated 52.8% of its genotypic effect on 2-year weight loss in response to a high-fat rather than a low-fat diet.
Our study is the first to incorporate analysis of a genetic variant, DNAm, and transcription in weight loss using diet interventions, and our results showed consistent gene-diet interactions at multiple omics levels. As the pathway of NFATC2IP rs11150675 A allele, a lower DNAm at cis (cg26663590), and a lower BMI that was identified by Wahl et al.
5
, our data not only validated the role of rs11150675 as cis-meQTL for cg26663590, but also supported the rs11150675 A allele, as well as a lower DNAm at cg26663590, was associated with greater weight-loss in respond to a high-fat diet. We further linked higher NFATC2IP gene expression with greater 2-year weight loss. As cg26663590 is located in the promoter region of the NFATC2IP locus, our finding also supported the well-accepted interaction between DNAm and gene expression, that is, hypomethylation at the promoter region leads to upregulation or activation of the cis-downstream gene expression, whereas hypermethylation acts as a barrier. 10 Therefore, we inferred a "stitched" pathway of the rs11150675 A allele -lower DNAm at cg26663590 -higher gene expression at the NFATC2IP locus, which was associated with greater weight loss in respond to a high-fat rather than a low-fat diet.
Intriguingly, our mediation analysis further confirmed the interconnected pathway of genetic, epigenetic and transcriptional variations at the NFATC2IP locus in relation to adiposity. We demonstrated cis-DNAm as a mediator for genetic effect on adiposity changes. Among participants in the high-fat group, we estimated a 52.8% impact of the NFATC2IP genotype on weight change that was mediated by the cis-DNAm at cg26663590, implying that DNAm variation might account for the major genotype effects. The functional role of NFATC2IP in adipose biology is unclear. Wahl et al. 5 mentioned that this gene encodes SH2B1, a key regulator of leptin, that affects obesity. In addition, NFATC2IP plays a role in cytokine production 11 and positive regulation of transcription by RNA polymerase II, 12 which might be the targeted genes or pathways influenced by calorie-restricted diets in previous weight-loss RCTs. [13] [14] [15] Further studies are warranted, to localize and validate this mediating process.
The major strengths of our study include multi-omics analysis, comprehensive and longitudinal measures of body fat and composition, and mediation analyses to indicate causality in an RCT setting.
However, several limitations merit discussion. First, although our study is thus far the largest and longest trial concerning diet intervention and weight loss, the relatively small sample size in subgroup analyses may have led to wide estimated 95% confidence intervals and limited power. Second, DNAm was measured only once at baseline; thus, longitudinal changes as the result of weight-loss diets were unable to be captured. Third, genetic, epigenetic and transcriptional variants were all analysed at the cisregion, and epistasis (DNAm and gene expression at trans-) was not considered. Fourth, methylation was measured in peripheral blood leukocytes and the transcriptome in subcutaneous adipose tissue. Thus, validation in a cell-and tissue-specific manner is required. Furthermore, the majority of our study participants were White, and whether our findings are generalizable to other ethnicities needs to be further investigated.
In summary, our results indicate that the NFATC2IP locus may interact with dietary fat at genetic, epigenetic and transcriptional levels, thus affecting on adiposity changes. Further investigations are warranted to validate our findings.
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